SMITH JASON DREW (General Counsel) sold 35.1% of their position (3.80K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $45.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2021ACC: 0001209191-21-067440
Officer· General Counsel
Since Aug 2020
-3.80K
Net shares
Net seller
$45.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.33K acquired · 12.14K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+8.33K
Price / share
—
Trade value
—
% of position
333.3%
11/30/2021
2.50K→10.83K
Ordinary Shares
Direct
Shares
−3.80K
Price / share
$12.03
Trade value
$45.75K
% of position
35.1%
11/30/2021
10.83K→7.03K
Total
Net shares
+4.53K
Net value
-$45.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/30/2021 | M · Option Exercise | +8.33K | — | — | 333.3% | 2.50K | 10.83K |
| Ordinary Shares Direct | 11/30/2021 | S · Sale | −3.80K | $12.03 | $45.75K | 35.1% | 10.83K | 7.03K |
| Total | +4.53K | -$45.75K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
8.33K shares
Shares
−8.33K
Strike price
Held after
16.67K
Exercisable
—
11/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares8.33K shares | 11/30/2021 | M · Option Exercise | −8.33K | — | 16.67K |